Nearly 300 non-invasive diagnostic tests, Claims Roots Analysis

Given the invasive and cost-intensive nature of tissue biopsies, there is a significant unmet need for safer and more patient-friendly cancer diagnostics that are capable of offering highly accurate, and actionable insights related to the disease.

 

To order this 350+ page report, which features 150+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html

The financial opportunity within the liquid biopsy and other non-invasive cancer diagnostics market has been analyzed across the following segments:

Type of Tumor Marker

ctDNAcfDNACTCsExosomesOthers

Application

Diagnosis / Early DiagnosisPatient MonitoringRecurrence Monitoring

Target Cancer Indication

Breast CancerLung CancerColorectal CancerProstate CancerBladder CancerMelanomaGastric CancerPancreatic CancerOvarian CancerOthers

End Users

HospitalsResearch InstitutesOthers

Key Geographical Regions

North AmericaEuropeAsia-PacificRest of the World

The “Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers.”report features the following companies, which we identified to be key players in this domain:

Amoy Diagnostics

DiaCarta

HaploX Biotechnology

NeoGenomics

QIAGEN

Swift Biosciences

Sysmex Inostics

Thermo Fisher Scientific

To request for sample report - https://www.rootsanalysis.com/reports/279/request-sample.html

 

Table of Contents

 

1. Preface

2. Executive Summary

3. Introduction

 

4. Non-Invasive Cancer Screening and Diagnosis

 

5. Market Landscape

 

 

 

6. Company Profiles 

 

7. Partnerships and Collaborations

 

 

 

8. Funding and Investment Analysis

 

9. Liquid Biopsy: Initiatives of Big Pharma Players

 

10. Key Acquisition Targets

 

 

 

11. Other Non-Invasive Cancer Diagnostics

 

12. Market Sizing and Opportunity Analysis

 

13. Survey Insights

 

 

 

14. Conclusion

 

15. Executive Insights

 

 

 

16. Appendix 1: Tabulated Data

 

 

 

17. Appendix 2: List of Companies and Organizations

 

 

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html

  

About Roots Analysis

 

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

  

Other Recent Offerings:

 Antibody Drug Conjugates Market (5th Edition), 2019-2030Gene Therapy Market (3rd Edition), 2019 - 2030Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019 – 2030  

Contact Information

 

Roots Analysis Private Limited

 

Gaurav Chaudhary

 

+1 (415) 800 3415

 

[email protected]

 

Facebook - https://www.facebook.com/RootsAnalysis

 

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

 Twitter - https://twitter.com/RootsAnalysis